Brief-Endovia Health Sciences Advances Cannepil FDA Submission, Expands Pipeline
EDVA•Endovia advances Cannepil submission and pipeline plans
Aug. 31 (Reuters) - Endovia Health Sciences, Inc. EDVA.A:
- Endovia Health Sciences welcomes federal cannabinoid policy shift, advances Cannepil FDA submission, expands pipeline - SEC filing
- Endovia Health Sciences is to submit Cannepil FDA submission and request pre-submission conference in coming week - SEC filing
- Endovia Health Sciences is also actively reviewing additional cannabinoid formulations and IP for licensing, acquisition, collaboration - SEC filing
- Endovia Health Sciences is working to finalize expanded financing for development, licensing, acquisition, operations - SEC filing
